Reviews - 2pc0 mentioned but not cited (3)
- The Determination of HIV-1 RT Mutation Rate, Its Possible Allosteric Effects, and Its Implications on Drug Resistance. Yeo JY, Goh GR, Su CT, Gan SK. Viruses 12 E297 (2020)
- Pepsin-like aspartic proteases (PAPs) as model systems for combining biomolecular simulation with biophysical experiments. Bhakat S. RSC Adv 11 11026-11047 (2021)
- Comprehending the Structure, Dynamics, and Mechanism of Action of Drug-Resistant HIV Protease. Dakshinamoorthy A, Asmita A, Senapati S. ACS Omega 8 9748-9763 (2023)
Articles - 2pc0 mentioned but not cited (20)
- Modelling dynamics in protein crystal structures by ensemble refinement. Burnley BT, Afonine PV, Adams PD, Gros P. Elife 1 e00311 (2012)
- HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements. Agniswamy J, Shen CH, Aniana A, Sayer JM, Louis JM, Weber IT. Biochemistry 51 2819-2828 (2012)
- Fragment-based screen against HIV protease. Perryman AL, Zhang Q, Soutter HH, Rosenfeld R, McRee DE, Olson AJ, Elder JE, Stout CD. Chem Biol Drug Des 75 257-268 (2010)
- Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics. Agniswamy J, Louis JM, Roche J, Harrison RW, Weber IT. PLoS One 11 e0168616 (2016)
- Long-Range Electrostatics-Induced Two-Proton Transfer Captured by Neutron Crystallography in an Enzyme Catalytic Site. Gerlits O, Wymore T, Das A, Shen CH, Parks JM, Smith JC, Weiss KL, Keen DA, Blakeley MP, Louis JM, Langan P, Weber IT, Kovalevsky A. Angew Chem Int Ed Engl 55 4924-4927 (2016)
- Small molecule regulation of protein conformation by binding in the Flap of HIV protease. Tiefenbrunn T, Forli S, Baksh MM, Chang MW, Happer M, Lin YC, Perryman AL, Rhee JK, Torbett BE, Olson AJ, Elder JH, Finn MG, Stout CD. ACS Chem Biol 8 1223-1231 (2013)
- Defective hydrophobic sliding mechanism and active site expansion in HIV-1 protease drug resistant variant Gly48Thr/Leu89Met: mechanisms for the loss of saquinavir binding potency. Goldfarb NE, Ohanessian M, Biswas S, McGee TD, Mahon BP, Ostrov DA, Garcia J, Tang Y, McKenna R, Roitberg A, Dunn BM. Biochemistry 54 422-433 (2015)
- Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes. Robbins AH, Coman RM, Bracho-Sanchez E, Fernandez MA, Gilliland CT, Li M, Agbandje-McKenna M, Wlodawer A, Dunn BM, McKenna R. Acta Crystallogr D Biol Crystallogr 66 233-242 (2010)
- BP-Dock: a flexible docking scheme for exploring protein-ligand interactions based on unbound structures. Bolia A, Gerek ZN, Ozkan SB. J Chem Inf Model 54 913-925 (2014)
- Conformational variation of an extreme drug resistant mutant of HIV protease. Shen CH, Chang YC, Agniswamy J, Harrison RW, Weber IT. J Mol Graph Model 62 87-96 (2015)
- Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma. Fassmannová D, Sedlák F, Sedláček J, Špička I, Grantz Šašková K. Cancers (Basel) 12 E1065 (2020)
- Structures of darunavir-resistant HIV-1 protease mutant reveal atypical binding of darunavir to wide open flaps. Zhang Y, Chang YC, Louis JM, Wang YF, Harrison RW, Weber IT. ACS Chem Biol 9 1351-1358 (2014)
- Transient HIV-1 Gag-protease interactions revealed by paramagnetic NMR suggest origins of compensatory drug resistance mutations. Deshmukh L, Louis JM, Ghirlando R, Clore GM. Proc Natl Acad Sci U S A 113 12456-12461 (2016)
- Drug Resistance Mutation L76V Alters Nonpolar Interactions at the Flap-Core Interface of HIV-1 Protease. Wong-Sam A, Wang YF, Zhang Y, Ghosh AK, Harrison RW, Weber IT. ACS Omega 3 12132-12140 (2018)
- Atomistic simulations of the HIV-1 protease folding inhibition. Verkhivker G, Tiana G, Camilloni C, Provasi D, Broglia RA. Biophys J 95 550-562 (2008)
- Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance. Nakashima M, Ode H, Suzuki K, Fujino M, Maejima M, Kimura Y, Masaoka T, Hattori J, Matsuda M, Hachiya A, Yokomaku Y, Suzuki A, Watanabe N, Sugiura W, Iwatani Y. Front Microbiol 7 61 (2016)
- Designing Fluorescent Peptide Sensors with Dual Specificity for the Detection of HIV-1 Protease. Herpoldt KL, Artzy-Schnirman A, Christofferson AJ, Makarucha AJ, de la Rica R, Yarovsky I, Stevens MM. Chem Mater 27 7187-7195 (2015)
- A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF. Yedidi RS, Proteasa G, Martin PD, Liu Z, Vickrey JF, Kovari IA, Kovari LC. J Mol Graph Model 53 105-111 (2014)
- Evolution of drug resistance drives destabilization of flap region dynamics in HIV-1 protease. Rajendran M, Ferran MC, Mouli L, Babbitt GA, Lynch ML. Biophys Rep (N Y) 3 100121 (2023)
- Revertant mutation V48G alters conformational dynamics of highly drug resistant HIV protease PRS17. Burnaman SH, Kneller DW, Wang YF, Kovalevsky A, Weber IT. J Mol Graph Model 108 108005 (2021)
Reviews citing this publication (4)
- Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS. Ghosh AK, Osswald HL, Prato G. J Med Chem 59 5172-5208 (2016)
- New antivirals and drug resistance. Colman PM. Annu Rev Biochem 78 95-118 (2009)
- Charting a Path to Success in Virtual Screening. Forli S. Molecules 20 18732-18758 (2015)
- Sequence, Structural Analysis and Metrics to Define the Unique Dynamic Features of the Flap Regions Among Aspartic Proteases. McGillewie L, Ramesh M, Soliman ME. Protein J 36 385-396 (2017)
Articles citing this publication (41)
- A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. Giffin MJ, Heaslet H, Brik A, Lin YC, Cauvi G, Wong CH, McRee DE, Elder JH, Stout CD, Torbett BE. J Med Chem 51 6263-6270 (2008)
- Differential Flap Dynamics in Wild-type and a Drug Resistant Variant of HIV-1 Protease Revealed by Molecular Dynamics and NMR Relaxation. Cai Y, Yilmaz NK, Myint W, Ishima R, Schiffer CA. J Chem Theory Comput 8 3452-3462 (2012)
- Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir. Liu F, Kovalevsky AY, Tie Y, Ghosh AK, Harrison RW, Weber IT. J Mol Biol 381 102-115 (2008)
- PagP crystallized from SDS/cosolvent reveals the route for phospholipid access to the hydrocarbon ruler. Cuesta-Seijo JA, Neale C, Khan MA, Moktar J, Tran CD, Bishop RE, Pomès R, Privé GG. Structure 18 1210-1219 (2010)
- Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility. Kear JL, Blackburn ME, Veloro AM, Dunn BM, Fanucci GE. J Am Chem Soc 131 14650-14651 (2009)
- Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease. de Vera IM, Smith AN, Dancel MC, Huang X, Dunn BM, Fanucci GE. Biochemistry 52 3278-3288 (2013)
- Flap dynamics of plasmepsin proteases: insight into proposed parameters and molecular dynamics. Karubiu W, Bhakat S, Bhakat S, McGillewie L, Soliman ME. Mol Biosyst 11 1061-1066 (2015)
- Conformation of inhibitor-free HIV-1 protease derived from NMR spectroscopy in a weakly oriented solution. Roche J, Louis JM, Bax A. Chembiochem 16 214-218 (2015)
- Relating sequence evolution of HIV1-protease to its underlying molecular mechanics. Hamacher K. Gene 422 30-36 (2008)
- Evidence that the Bacillus subtilis SpoIIGA protein is a novel type of signal-transducing aspartic protease. Imamura D, Zhou R, Feig M, Kroos L. J Biol Chem 283 15287-15299 (2008)
- DEER-PREdict: Software for efficient calculation of spin-labeling EPR and NMR data from conformational ensembles. Tesei G, Martins JM, Kunze MBA, Wang Y, Crehuet R, Lindorff-Larsen K. PLoS Comput Biol 17 e1008551 (2021)
- Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors. Böttcher J, Blum A, Dörr S, Heine A, Diederich WE, Klebe G. ChemMedChem 3 1337-1344 (2008)
- Dynamic flaps in HIV-1 protease adopt unique ordering at different stages in the catalytic cycle. Karthik S, Senapati S. Proteins 79 1830-1840 (2011)
- Efficient inclusion of receptor flexibility in grid-based protein-ligand docking. Leis S, Zacharias M. J Comput Chem 32 3433-3439 (2011)
- Elastic potential grids: accurate and efficient representation of intermolecular interactions for fully flexible docking. Kazemi S, Krüger DM, Sirockin F, Gohlke H. ChemMedChem 4 1264-1268 (2009)
- Research Support, Non-U.S. Gov't Flap Dynamics in Aspartic Proteases: A Computational Perspective. Mahanti M, Bhakat S, Bhakat S, Nilsson UJ, Söderhjelm P. Chem Biol Drug Des 88 159-177 (2016)
- Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights. Chetty S, Bhakat S, Bhakat S, Martin AJ, Soliman ME. J Biomol Struct Dyn 34 135-151 (2016)
- Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance. Naicker P, Achilonu I, Fanucchi S, Fernandes M, Ibrahim MA, Dirr HW, Soliman ME, Sayed Y. J Biomol Struct Dyn 31 1370-1380 (2013)
- [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA]. Li X, Fan R, Zou X, Hong L, Gao L, Jin H, Du R, He L, Xia L, Fan D. Mol Biol (Mosk) 42 102-109 (2008)
- Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses. McGillewie L, Soliman ME. Proteins 83 1693-1705 (2015)
- Molecular Docking: From Lock and Key to Combination Lock. Tripathi A, Bankaitis VA. J Mol Med Clin Appl 2 (2017)
- Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts. Liu Z, Casey TM, Blackburn ME, Huang X, Pham L, de Vera IM, Carter JD, Kear-Scott JL, Veloro AM, Galiano L, Fanucci GE. Phys Chem Chem Phys 18 5819-5831 (2016)
- Understanding HIV-1 protease autoprocessing for novel therapeutic development. Huang L, Chen C. Future Med Chem 5 1215-1229 (2013)
- Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational sampling. Carter JD, Gonzales EG, Huang X, Smith AN, de Vera IM, D'Amore PW, Rocca JR, Goodenow MM, Dunn BM, Fanucci GE. FEBS Lett 588 3123-3128 (2014)
- On the orientation of the catalytic dyad in aspartic proteases. Friedman R, Caflisch A. Proteins 78 1575-1582 (2010)
- A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network. Rücker P, Horn AH, Meiselbach H, Sticht H. J Mol Model 17 2693-2705 (2011)
- Variation of protein binding cavity volume and ligand volume in protein-ligand complexes. Saranya N, Selvaraj S. Bioorg Med Chem Lett 19 5769-5772 (2009)
- A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility. Kumalo HM, Soliman ME. J Recept Signal Transduct Res 36 505-514 (2016)
- Crystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compounds. Yedidi RS, Liu Z, Wang Y, Brunzelle JS, Kovari IA, Woster PM, Kovari LC, Gupta D. Biochem Biophys Res Commun 421 413-417 (2012)
- MFPred: Rapid and accurate prediction of protein-peptide recognition multispecificity using self-consistent mean field theory. Rubenstein AB, Pethe MA, Khare SD. PLoS Comput Biol 13 e1005614 (2017)
- Enhanced conformational sampling technique provides an energy landscape view of large-scale protein conformational transitions. Shao Q. Phys Chem Chem Phys 18 29170-29182 (2016)
- Unraveling HIV protease flaps dynamics by Constant pH Molecular Dynamics simulations. Soares RO, Torres PHM, da Silva ML, Pascutti PG. J Struct Biol 195 216-226 (2016)
- Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease. Lin YC, Torbett BE, Elder JH. J Virol 84 6799-6809 (2010)
- Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis. Mata-Munguía C, Escoto-Delgadillo M, Torres-Mendoza B, Flores-Soto M, Vázquez-Torres M, Gálvez-Gastelum F, Viniegra-Osorio A, Castillero-Manzano M, Vázquez-Valls E. BMC Bioinformatics 15 72 (2014)
- Amide hydrogen exchange in HIV-1 subtype B and C proteases--insights into reduced drug susceptibility and dimer stability. Naicker P, Stoychev S, Dirr HW, Sayed Y. FEBS J 281 5395-5410 (2014)
- Mining the protein data bank to differentiate error from structural variation in clustered static structures: an examination of HIV protease. Venkatakrishnan B, Palii ML, Agbandje-McKenna M, McKenna R. Viruses 4 348-362 (2012)
- Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their Inhibition. Vanangamudi M, Nair PC, Engels SEM, Palaniappan S, Namasivayam V. Adv Exp Med Biol 1322 63-95 (2021)
- Structural basis of drug resistance by genetic variants of HIV type 1 clade c protease from India. Kandathil AJ, Joseph AP, Kannangai R, Srinivasan N, Abraham OC, Pulimood SA, Sridharan G. AIDS Res Hum Retroviruses 25 511-519 (2009)
- Dataset showing the impact of the protonation states on molecular dynamics of HIV protease. Soares RO, Torres PH, da Silva ML, Pascutti PG. Data Brief 8 1144-1150 (2016)
- Developing HIV-1 Protease Inhibitors through Stereospecific Reactions in Protein Crystals. Olajuyigbe FM, Demitri N, De Zorzi R, Geremia S. Molecules 21 E1458 (2016)
- HIV-1 protease with 10 lopinavir and darunavir resistance mutations exhibits altered inhibition, structural rearrangements and extreme dynamics. Wong-Sam A, Wang YF, Kneller DW, Kovalevsky AY, Ghosh AK, Harrison RW, Weber IT. J Mol Graph Model 117 108315 (2022)